Tachykinin antagonists
US5856354A · kind A · utility
1Cited by
1References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 1997 |
| Grant date | Jan 5, 1999 |
| Priority date | — |
| Expiry date | Oct 17, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns tachykinin antagonists. The compounds are neopeptides which have utility in treating disorders mediated by tachykinins. Such disorders are respiratory, inflammatory, gastrointestinal, ophthalmic, allergies, pain, vascular, diseases of the central nervous system, and migraine. Methods of preparing compounds and novel intermediates are also included. The compounds are expected to be especially useful in asthma and rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.